SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary Syndrome

Purpose. To investigate in a pilot study of genetic polymorphisms in serotonin system influencing basal- and glucose-stimulated insulin secretion in women with polycystic ovary syndrome (PCOS). Methods. A cross-sectional study included 65 female patients with PCOS followed up at the endocrine outpat...

Full description

Saved in:
Bibliographic Details
Main Authors: Barbara Šenk, Katja Goričar, Nika Aleksandra Kravos, Mojca Jensterle Sever, Andrej Janež, Vita Dolžan
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2018/6130487
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559490992439296
author Barbara Šenk
Katja Goričar
Nika Aleksandra Kravos
Mojca Jensterle Sever
Andrej Janež
Vita Dolžan
author_facet Barbara Šenk
Katja Goričar
Nika Aleksandra Kravos
Mojca Jensterle Sever
Andrej Janež
Vita Dolžan
author_sort Barbara Šenk
collection DOAJ
description Purpose. To investigate in a pilot study of genetic polymorphisms in serotonin system influencing basal- and glucose-stimulated insulin secretion in women with polycystic ovary syndrome (PCOS). Methods. A cross-sectional study included 65 female patients with PCOS followed up at the endocrine outpatient clinic of the University Medical Center Ljubljana and a control group of 94 young healthy female blood donors. Oral glucose tolerance test was performed only in PCOS patients and basal- and glucose-stimulated blood glucose and insulin levels were measured. All the subjects were genotyped for 5HTR1A rs6295, 5HTR1B rs13212041, and SLC6A4 5HTTLPR polymorphisms in the serotonin system. Results. Genotype distributions were in accordance with the Hardy-Weinberg equilibrium (HWE), except for 5HTR1A rs6295 in healthy controls and 5HTR1B rs13212041 in PCOS patients that were not consistent with HWE. SLC6A4 5HTTLPR polymorphism was significantly associated with insulin secretion (p=0.030) and with the area under the curve of insulin blood levels during OGTT (p=0.021). None of the investigated polymorphisms was significantly associated with basal- or glucose-stimulated blood glucose levels at any point in time during OGTT or with the basal insulin concentration. Conclusions. Serotonin system may play a role in glucose-stimulated insulin secretion in patients with insulin resistance (IR) and decreased insulin sensitivity. Further studies are needed to conclude whether the observed effect is characteristic for PCOS-related metabolic disturbances or for the identified mutation in different high metabolic risk populations.
format Article
id doaj-art-768d377cdfb84d88846701ac5043ede2
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-768d377cdfb84d88846701ac5043ede22025-02-03T01:29:53ZengWileyInternational Journal of Endocrinology1687-83371687-83452018-01-01201810.1155/2018/61304876130487SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary SyndromeBarbara Šenk0Katja Goričar1Nika Aleksandra Kravos2Mojca Jensterle Sever3Andrej Janež4Vita Dolžan5Faculty of Medicine, Institute of Biochemistry, Pharmacogenetics Laboratory, University of Ljubljana, Vrazov Trg 2, 1000 Ljubljana, SloveniaFaculty of Medicine, Institute of Biochemistry, Pharmacogenetics Laboratory, University of Ljubljana, Vrazov Trg 2, 1000 Ljubljana, SloveniaDepartment of Endocrinology, Diabetes and Metabolic Diseases, University Medical Center Ljubljana, Zaloška Cesta 7, 1000 Ljubljana, SloveniaDepartment of Endocrinology, Diabetes and Metabolic Diseases, University Medical Center Ljubljana, Zaloška Cesta 7, 1000 Ljubljana, SloveniaDepartment of Endocrinology, Diabetes and Metabolic Diseases, University Medical Center Ljubljana, Zaloška Cesta 7, 1000 Ljubljana, SloveniaFaculty of Medicine, Institute of Biochemistry, Pharmacogenetics Laboratory, University of Ljubljana, Vrazov Trg 2, 1000 Ljubljana, SloveniaPurpose. To investigate in a pilot study of genetic polymorphisms in serotonin system influencing basal- and glucose-stimulated insulin secretion in women with polycystic ovary syndrome (PCOS). Methods. A cross-sectional study included 65 female patients with PCOS followed up at the endocrine outpatient clinic of the University Medical Center Ljubljana and a control group of 94 young healthy female blood donors. Oral glucose tolerance test was performed only in PCOS patients and basal- and glucose-stimulated blood glucose and insulin levels were measured. All the subjects were genotyped for 5HTR1A rs6295, 5HTR1B rs13212041, and SLC6A4 5HTTLPR polymorphisms in the serotonin system. Results. Genotype distributions were in accordance with the Hardy-Weinberg equilibrium (HWE), except for 5HTR1A rs6295 in healthy controls and 5HTR1B rs13212041 in PCOS patients that were not consistent with HWE. SLC6A4 5HTTLPR polymorphism was significantly associated with insulin secretion (p=0.030) and with the area under the curve of insulin blood levels during OGTT (p=0.021). None of the investigated polymorphisms was significantly associated with basal- or glucose-stimulated blood glucose levels at any point in time during OGTT or with the basal insulin concentration. Conclusions. Serotonin system may play a role in glucose-stimulated insulin secretion in patients with insulin resistance (IR) and decreased insulin sensitivity. Further studies are needed to conclude whether the observed effect is characteristic for PCOS-related metabolic disturbances or for the identified mutation in different high metabolic risk populations.http://dx.doi.org/10.1155/2018/6130487
spellingShingle Barbara Šenk
Katja Goričar
Nika Aleksandra Kravos
Mojca Jensterle Sever
Andrej Janež
Vita Dolžan
SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary Syndrome
International Journal of Endocrinology
title SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary Syndrome
title_full SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary Syndrome
title_fullStr SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary Syndrome
title_full_unstemmed SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary Syndrome
title_short SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary Syndrome
title_sort slc6a4 5httlpr polymorphism affects insulin secretion in patients with polycystic ovary syndrome
url http://dx.doi.org/10.1155/2018/6130487
work_keys_str_mv AT barbarasenk slc6a45httlprpolymorphismaffectsinsulinsecretioninpatientswithpolycysticovarysyndrome
AT katjagoricar slc6a45httlprpolymorphismaffectsinsulinsecretioninpatientswithpolycysticovarysyndrome
AT nikaaleksandrakravos slc6a45httlprpolymorphismaffectsinsulinsecretioninpatientswithpolycysticovarysyndrome
AT mojcajensterlesever slc6a45httlprpolymorphismaffectsinsulinsecretioninpatientswithpolycysticovarysyndrome
AT andrejjanez slc6a45httlprpolymorphismaffectsinsulinsecretioninpatientswithpolycysticovarysyndrome
AT vitadolzan slc6a45httlprpolymorphismaffectsinsulinsecretioninpatientswithpolycysticovarysyndrome